Vitalist sets September 29 date for annual shareholder meeting

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights

Vitalist Inc. announced its Annual and Special Meeting for September 29, 2026, in Calgary, setting August 12, 2026, as the record date. Shareholders will consider financial statements for the fiscal year ended March 31, 2026, elect six directors, and appoint Davidson & Company LLP as auditors. The meeting also includes the re-approval of the Amended and Restated 2024 Omnibus Equity Incentive Plan.

powered bylight_fuzz_icon
45868802

*this image is generated using AI for illustrative purposes only.

Vitalist Inc. will hold its Annual and Special Meeting on September 29, 2026, at 10:00 AM MST in Calgary, Alberta. The meeting will take place at 2100 Livingston Place, 222 3 Ave SW, Calgary, AB T2P 0B4. Shareholders of record as of August 12, 2026, are entitled to participate and vote at the meeting.

The agenda includes receiving the financial statements for the fiscal year ended March 31, 2026, and the auditors' report. Vitalist's Board proposes fixing the number of directors at six for the ensuing year. Shareholders will also vote to elect directors and appoint Davidson & Company LLP as the Company's auditors, authorizing the directors to fix their remuneration.

Another key item is the re-approval of the Amended and Restated 2024 Omnibus Equity Incentive Plan. The meeting may also transact any other business properly brought before it.

Meeting Details

Item Details
Meeting Date September 29, 2026
Time 10:00 AM MST
Location 2100 Livingston Place, 222 3 Ave SW, Calgary, AB T2P 0B4
Record Date August 12, 2026

Vitalist Inc. is a wearable operating-system focused technology company. Through its VitalOS platform, the company enables brands to create connected devices and applications.

What strategic priorities will the newly elected directors focus on following the meeting?

How might the re-approval of the equity incentive plan impact shareholder value and employee retention?

What are the expected growth drivers for Vitalist's VitalOS platform in the upcoming fiscal year?

like16
dislike

Vitalist CRO Nick Padula departs post Somatix integration

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

Vitalist Inc. announced the departure of Chief Revenue Officer Nick Padula following the integration of Somatix Inc. Commercial and sales operations will now report directly to CEO Kalvie Legat, while health and wellness business development remains under Dr. Charles Herman.

powered bylight_fuzz_icon
44549120

*this image is generated using AI for illustrative purposes only.

Vitalist Inc. announced that Chief Revenue Officer Nick Padula will depart the company following his support of the post-acquisition integration and commercial transition of Somatix Inc. The leadership change marks the completion of the integration phase for the subsidiary acquired by Vitalist.

Nick Padula and the Vitalist team are collaborating to ensure a seamless hand-off of responsibilities over the coming weeks. The company expressed appreciation for Mr. Padula's leadership during his tenure, specifically regarding his efforts in guiding the integration and transition since the acquisition of Somatix Inc.

In connection with the departure, Vitalist is restructuring its reporting hierarchy. Commercial and sales operations will now report directly to CEO Kalvie Legat. Additionally, health and wellness business development will continue to report through Dr. Charles Herman, who serves as the Chief Scientific Officer (CSO) of Vitalist and CEO of Somatix Inc.

Organizational Structure

The following table outlines the updated reporting lines within Vitalist Inc.:

Function Reporting Executive Title
Commercial and Sales Operations Kalvie Legat CEO
Health and Wellness Business Development Dr. Charles Herman CSO, Vitalist; CEO, Somatix Inc.

Vitalist Inc. is a technology provider that enables brands to create connected devices and applications through its VitalOS platform. The company focuses on uniting hardware and software with intelligent analytics to build personalized solutions.

How will the direct reporting of commercial and sales operations to the CEO impact Vitalist's go-to-market strategy?

Does the departure of the CRO signal a shift in focus from post-acquisition integration to organic growth?

Who will Vitalist appoint to lead commercial strategy, and will they prioritize hardware or software solutions?

like16
dislike

More News on Vitalist Inc.